Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Prostate Cancer

  Free Subscription


Articles published in Int J Urol

Retrieve available abstracts of 88 articles:
HTML format



Single Articles


    May 2008
  1. ZHANG P , Zeng H, Wei Q, Lu Y, et al
    Improved effects of a double suicide gene system on prostate cancer cells by targeted regulation of prostate-specific membrane antigen promoter and enhancer.
    Int J Urol. 2008;15:442-8.
    PubMed     Related articles    Abstract available


  2. OZU C , Nakashima J, Horiguchi Y, Oya M, et al
    Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
    Int J Urol. 2008;15:419-22.
    PubMed     Related articles    Abstract available


    April 2008
  3. IMAMOTO T , Suzuki H, Yano M, Kawamura K, et al
    The role of testosterone in the pathogenesis of prostate cancer.
    Int J Urol. 2008;.
    PubMed     Related articles    Abstract available


  4. NISHIMOTO K , Nakashima J, Hashiguchi A, Kikuchi E, et al
    Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Int J Urol. 2008;.
    PubMed     Related articles    Abstract available


  5. SUGIMOTO M , Takegami M, Suzukamo Y, Fukuhara S, et al
    Health-related quality of life in Japanese men with localized prostate cancer: Assessment with the SF-8.
    Int J Urol. 2008;.
    PubMed     Related articles    Abstract available


  6. NOZAKI T , Yasuda K, Akashi T, Fuse H, et al
    Usefulness of single photon emission computed tomography imaging in the detection of lumbar vertebral metastases from prostate cancer.
    Int J Urol. 2008;.
    PubMed     Related articles    Abstract available


  7. KUBOTA Y , Kamei S, Nakano M, Ehara H, et al
    The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
    Int J Urol. 2008;15:322-6.
    PubMed     Related articles    Abstract available


  8. IMAMURA T , Yasunaga H
    Economic evaluation of prostate cancer screening with prostate-specific antigen.
    Int J Urol. 2008;15:285-8.
    PubMed     Related articles    Abstract available


    March 2008
  9. KOIE T , Yoneyama T, Kamimura N, Imai A, et al
    Frequency of postoperative inguinal hernia after endoscope-assisted mini-laparotomy and conventional retropubic radical prostatectomies.
    Int J Urol. 2008;15:226-9.
    PubMed     Related articles    Abstract available


    February 2008
  10. IKEDA T , Shinohara K
    Comparison of prostate and transition zone volume measured by the ellipsoid and planimetric methods with transrectal ultrasonography before seed implantation of prostate cancer.
    Int J Urol. 2008;15:190-1.
    PubMed     Related articles    Abstract available


  11. OKIHARA K , Kitamura K, Okada K, Mikami K, et al
    Ten year trend in prostate cancer screening with high prostate-specific antigen exposure rate in Japan.
    Int J Urol. 2008;15:156-60.
    PubMed     Related articles    Abstract available


    January 2008
  12. TAKENAKA A , Yamada Y, Kurahashi T, Soga H, et al
    Combination chemotherapy with weekly docetaxel and estramustine for hormone refractory prostate cancer in Japanese patients.
    Int J Urol. 2008;15:106-9.
    PubMed     Related articles    Abstract available


  13. YASUNAGA H
    Willingness to pay for mass screening for prostate cancer: A contingent valuation survey.
    Int J Urol. 2008;15:102-5.
    PubMed     Related articles    Abstract available


  14. ZALESKY M , Urban M, Smerhovsky Z, Zachoval R, et al
    Value of power Doppler sonography with 3D reconstruction in preoperative diagnostics of extraprostatic tumor extension in clinically localized prostate cancer.
    Int J Urol. 2008;15:68-75.
    PubMed     Related articles    Abstract available


  15. UEMURA H , Ishiguro H, Kubota Y
    Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment.
    Int J Urol. 2008;15:19-26.
    PubMed     Related articles    Abstract available


  16. KAMIDONO S , Ohshima S, Hirao Y, Suzuki K, et al
    Evidence-based Clinical Practice Guidelines for Prostate Cancer (Summary - JUA 2006 Edition).
    Int J Urol. 2008;15:1-18.
    PubMed     Related articles   


    December 2007
  17. ISHIZAKA K , Machida T, Kobayashi S, Kanbe N, et al
    Preventive effect of risedronate on bone loss in men receiving androgen-deprivation therapy for prostate cancer.
    Int J Urol. 2007;14:1071-5.
    PubMed     Related articles    Abstract available


  18. OGAN K , Kawai K, Gill IS, Naito S, et al
    The Second Joint Meeting of American Urological Association (AUA)/Japanese Urological Association (JUA) International Program on the 102nd Annual Meeting of American Urological Association at Anaheim 2007.
    Int J Urol. 2007;14:1116-23.
    PubMed     Related articles   


  19. KATO T , Hashimoto Y, Okada S, Tozawa K, et al
    Carbohydrate antigen 19-9-positive prostatic ductal adenocarcinoma effectively treated with cisplatin and gemcitabine.
    Int J Urol. 2007;14:1103-6.
    PubMed     Related articles    Abstract available


    November 2007
  20. JIANG YG , Luo Y, He DL, Li X, et al
    Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Int J Urol. 2007;14:1034-9.
    PubMed     Related articles    Abstract available


  21. BLOCK CA , Erickson B, Carney-Doebbling C, Gordon S, et al
    Personality, treatment choice and satisfaction in patients with localized prostate cancer.
    Int J Urol. 2007;14:1013-8.
    PubMed     Related articles    Abstract available


  22. HAYASHI M , Shinmei S, Asano K
    Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure after radical prostatectomy.
    Int J Urol. 2007;14:1048-50.
    PubMed     Related articles    Abstract available


  23. LI B , Suzuki K, Tsuru N, Ushiyama T, et al
    Retrospective comparative study of 59 cases of laparoscopic radical prostatectomy: transperitoneal anterior versus transperitoneal posterior approach.
    Int J Urol. 2007;14:1005-8.
    PubMed     Related articles    Abstract available


    October 2007
  24. NAMIKI S , Saito S, Tochigi T, Numata I, et al
    Psychological distress in Japanese men with localized prostate cancer.
    Int J Urol. 2007;14:924-9.
    PubMed     Related articles    Abstract available


  25. SAITO S , Murakami G
    Anatomical study of perineal pelvic lymphadenectomy.
    Int J Urol. 2007;14:978-80.
    PubMed     Related articles    Abstract available


  26. SHIGEMURA K , Arakawa S, Yamanaka K, Kataoka N, et al
    Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men.
    Int J Urol. 2007;14:935-8.
    PubMed     Related articles    Abstract available


  27. KINOSHITA H , Kamoto T, Nishiyama H, Nakamura E, et al
    Prostate specific antigen nadir determined using ultra-sensitive prostate specific antigen as a predictor of biochemical progression after radical prostatectomy in Japanese males.
    Int J Urol. 2007;14:930-4.
    PubMed     Related articles    Abstract available


    September 2007
  28. SUMURA M , Shigeno K, Hyuga T, Yoneda T, et al
    Initial evaluation of prostate cancer with real-time elastography based on step-section pathologic analysis after radical prostatectomy: A preliminary study.
    Int J Urol. 2007;14:811-6.
    PubMed     Related articles    Abstract available


  29. KOBAYASHI T , Goto R, Fukui T, Ogawa O, et al
    Impact of improvement in specificity of primary screening test on total cost of prostate cancer mass screening.
    Int J Urol. 2007;14:805-10.
    PubMed     Related articles    Abstract available


  30. SUZUKI M , Kurosaki T, Arai T, Sawabe M, et al
    The Val158Met polymorphism of the catechol-O-methyltransferase gene is not associated with the risk of sporadic or latent prostate cancer in Japanese men.
    Int J Urol. 2007;14:800-4.
    PubMed     Related articles    Abstract available


  31. YINGHAO S , Bo Y, Xiaofeng G
    Extragastrointestinal stromal tumor possibly originating from the prostate.
    Int J Urol. 2007;14:869-71.
    PubMed     Related articles    Abstract available


  32. GAO D , Xia Q, Lv J, Zhang H, et al
    Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo.
    Int J Urol. 2007;14:838-45.
    PubMed     Related articles    Abstract available


  33. ISHII J , Ohori M, Scardino P, Tsuboi T, et al
    Significance of the craniocaudal distribution of cancer in radical prostatectomy specimens.
    Int J Urol. 2007;14:817-21.
    PubMed     Related articles    Abstract available


    August 2007
  34. GOYA N , Koga S, Tomizawa Y, Onitsuka S, et al
    Effects of direct injection of dehydrated ethanol on PC3 human prostate cancer cells in nude mice: Preliminary study.
    Int J Urol. 2007;14:760-3.
    PubMed     Related articles    Abstract available


  35. SAITO S
    Prostate-specific antigen cut-off point of 2.5 ng/mL and increasing the number of prostate biopsies results in the detection of curable prostate cancer even in Japanese population.
    Int J Urol. 2007;14:709-12.
    PubMed     Related articles    Abstract available


  36. PARK EA , Lee HJ, Kim KG, Kim SH, et al
    Prediction of pathological stages before prostatectomy in prostate cancer patients: Analysis of 12 systematic prostate needle biopsy specimens.
    Int J Urol. 2007;14:704-708.
    PubMed     Related articles    Abstract available


  37. KAWAKAMI S , Yamamoto S, Numao N, Ishikawa Y, et al
    Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer.
    Int J Urol. 2007;14:719-24.
    PubMed     Related articles    Abstract available


  38. SUEKANE S , Noguchi M, Nakashima O, Yamada S, et al
    Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
    Int J Urol. 2007;14:713-8.
    PubMed     Related articles    Abstract available


    July 2007
  39. JOUNG JY , Yang SO, Jeong IG, Han KS, et al
    Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: Potential value in molecular staging of prostate cancer.
    Int J Urol. 2007;14:635-43.
    PubMed     Related articles    Abstract available


  40. OKANEYA T , Nishizawa S, Nakayama T, Kamigaito T, et al
    Permanent prostate brachytherapy for Japanese men: Results from initial 100 patients with prostate cancer.
    Int J Urol. 2007;14:602-6.
    PubMed     Related articles    Abstract available


    June 2007
  41. NANRI M , Nanri K, Fujiyama C, Tokuda Y, et al
    Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
    Int J Urol. 2007;14:505-9.
    PubMed     Related articles    Abstract available


  42. HARA I , Kawabata G, Tanaka K, Kanomata N, et al
    Oncological outcome of laparoscopic prostatectomy.
    Int J Urol. 2007;14:515-20.
    PubMed     Related articles    Abstract available


  43. KUWATA Y , Muneuchi G, Igawa HH, Tsukuda F, et al
    Dissociation of sexual function and sexual bother following autologous sural nerve grafting during radical prostatectomy.
    Int J Urol. 2007;14:510-4.
    PubMed     Related articles    Abstract available


    May 2007
  44. AZZOUZI AR , Stoppa-Lyonnet D, Roupret M, Larre S, et al
    BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families.
    Int J Urol. 2007;14:445-6.
    PubMed     Related articles    Abstract available


  45. KATO T , Komiya A, Suzuki H, Imamoto T, et al
    Effect of androgen deprivation therapy on quality of life in Japanese men with prostate cancer.
    Int J Urol. 2007;14:416-21.
    PubMed     Related articles    Abstract available


  46. FUKAGAI T , Maruyama K, Nagata M, Morita M, et al
    Practice patterns regarding prostate cancer and benign prostatic hyperplasia in Japanese primary care practitioners.
    Int J Urol. 2007;14:412-5.
    PubMed     Related articles    Abstract available


  47. HOSSEINI SY , Moharramzadeh M, Ghadian AR, Hooshyar H, et al
    Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
    Int J Urol. 2007;14:406-11.
    PubMed     Related articles    Abstract available


  48. HARA I , Tanaka K, Yamada Y, Miyake H, et al
    Usefulness of laparo- or retroperitoneoscopic biopsy for retroperitoneal lymph node swelling of unknown origin.
    Int J Urol. 2007;14:466-9.
    PubMed     Related articles    Abstract available


  49. MARUYAMA T , Yamamoto S, Nojima M, Morita N, et al
    Extramedullary relapse of acute lymphoblastic leukemia in childhood to the prostate.
    Int J Urol. 2007;14:447-9.
    PubMed     Related articles    Abstract available


  50. KATAOKA K , Akasaka Y, Nakajima K, Nagao K, et al
    Cushing syndrome associated with prostatic tumor adrenocorticotropic hormone (ACTH) expression after maximal androgen blockade therapy.
    Int J Urol. 2007;14:436-9.
    PubMed     Related articles    Abstract available


    April 2007
  51. NEWTON F , Burney S, Frydenberg M, Millar J, et al
    Assessing mood and general health-related quality of life among men treated in Australia for localized prostate cancer.
    Int J Urol. 2007;14:311-6.
    PubMed     Related articles    Abstract available


  52. HOSHII T , Nishiyama T, Toyabe S, Akazawa K, et al
    Evaluation of magnetic resonance imaging-based prostate-specific antigen density of the prostate in the diagnosis of prostate cancer.
    Int J Urol. 2007;14:305-10.
    PubMed     Related articles    Abstract available


  53. RODRIGUES P , Hering FO, Bruna P, Meller A, et al
    Comparative study of the protective effect of different intravenous bisphosphonates on the decrease in bone mineral density in patients submitted to radical prostatectomy undergoing androgen deprivation therapy. A prospective open-label controlled study.
    Int J Urol. 2007;14:317-20.
    PubMed     Related articles    Abstract available


    March 2007
  54. NISHIMURA K , Arichi N, Tokugawa S, Yoshioka I, et al
    Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer.
    Int J Urol. 2007;14:264-7.
    PubMed     Related articles    Abstract available


  55. IWASA Y , Mizokami A, Miwa S, Koshida K, et al
    Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Int J Urol. 2007;14:233-9.
    PubMed     Related articles    Abstract available


  56. PARK S , Wians FH Jr, Cadeddu JA
    Spurious prostate-specific antigen (PSA) recurrence after radical prostatectomy: interference by human antimouse heterophile antibodies.
    Int J Urol. 2007;14:251-3.
    PubMed     Related articles    Abstract available


  57. SOGA N , Onishi T, Arima K, Sugimura Y, et al
    Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.
    Int J Urol. 2007;14:192-6.
    PubMed     Related articles    Abstract available


  58. NAMIKI S , Saito S, Tochigi T, Ioritani N, et al
    Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy.
    Int J Urol. 2007;14:186-91.
    PubMed     Related articles    Abstract available


    February 2007
  59. SATOH A , Matsumoto K, Nakamura S
    Is interval from an initial biopsy a significant predictor of prostate cancer at repeat biopsies?
    Int J Urol. 2007;14:178.
    PubMed     Related articles   


  60. KANEKO T
    Re: Is interval from an initial biopsy a significant predictor of prostate cancer at repeat biopsies?
    Int J Urol. 2007;14:177.
    PubMed     Related articles   


  61. CARAMELLO V , Dovio A, Caraci P, Berruti A, et al
    Thrombotic thrombocytopenic purpura in advanced prostate cancer: Case report and published work review.
    Int J Urol. 2007;14:150-2.
    PubMed     Related articles    Abstract available


  62. KINEBUCHI Y , Noguchi W, Irie K, Nakayama T, et al
    Relapsed prostate cancer with neuroendocrine differentiation and high serum levels of carcinoembryonic antigen without elevation of prostrate-specific antigen: A case report.
    Int J Urol. 2007;14:147-9.
    PubMed     Related articles    Abstract available


  63. OKIHARA K , Ukimura O, Kanemitsu N, Mizutani Y, et al
    Clinical efficacy of alternative antiandrogen therapy in Japanese men with relapsed prostate cancer after first-line hormonal therapy.
    Int J Urol. 2007;14:128-32.
    PubMed     Related articles    Abstract available


  64. TOMIOKA S , Shimbo M, Amiya Y, Nakatsu H, et al
    Significance of prostate-specific antigen-doubling time on survival of patients with hormone refractory prostate cancer and bone metastasis: Analysis on 56 cases of cancer-specific death.
    Int J Urol. 2007;14:123-7.
    PubMed     Related articles    Abstract available


  65. YOON CY , Sung DJ, Lee JH, Kim AR, et al
    Imaging of renal and prostate carcinoma with refractive index radiology.
    Int J Urol. 2007;14:96-103.
    PubMed     Related articles    Abstract available


  66. LAWRENTSCHUK N , Davis ID, Bolton DM, Scott AM, et al
    Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: Current practice.
    Int J Urol. 2007;14:89-95.
    PubMed     Related articles    Abstract available


    January 2007
  67. KIKUNO N , Urakami S, Nakamura S, Shiina H, et al
    Effect of zoledronic acid on metastatic hormone-refractory prostate cancer resistant to taxane, estramustine, carboplatin, and dexamethasone.
    Int J Urol. 2007;14:82-4.
    PubMed     Related articles    Abstract available


  68. PREZIOSO D , Denis LJ, Klocker H, Sciarra A, et al
    Estrogens and aspects of prostate disease.
    Int J Urol. 2007;14:1-16.
    PubMed     Related articles    Abstract available


    December 2006
  69. MIYANAGA N , Akaza H, Yamakawa M, Oikawa T, et al
    Tissue elasticity imaging for diagnosis of prostate cancer: A preliminary report.
    Int J Urol. 2006;13:1514-8.
    PubMed     Related articles    Abstract available


  70. UENO S , Namiki M, Fukagai T, Ehara H, et al
    Efficacy of primary hormonal therapy for patients with localized and locally advanced prostate cancer: A retrospective multicenter study.
    Int J Urol. 2006;13:1494-500.
    PubMed     Related articles    Abstract available


  71. TSURUMAKI Y , Tomita K, Kume H, Yamaguchi T, et al
    Predictors of seminal vesicle invasion before radical prostatectomy.
    Int J Urol. 2006;13:1501-8.
    PubMed     Related articles    Abstract available


  72. TERAI A , Ichioka K, Kohei N, Ueda N, et al
    Antibiotic prophylaxis in radical prostatectomy: 1-day versus 4-day treatments.
    Int J Urol. 2006;13:1488-93.
    PubMed     Related articles    Abstract available


    October 2006
  73. DUTTA ROY S , Philip J, Javle P
    Trends in prostate cancer incidence and survival in various socioeconomic classes: a population-based study.
    Int J Urol. 2006;13:1364.
    PubMed     Related articles   


  74. NOGUCHI M , Deguchi D, Toriwaki J, Mori K, et al
    Evaluation of a prostate biopsy strategy for cancer detection using a computer simulation system with virtual needle biopsy for three-dimensional prostate models.
    Int J Urol. 2006;13:1296-303.
    PubMed     Related articles    Abstract available


  75. MATSUMOTO K , Egawa S, Satoh T, Kuruma H, et al
    Computer simulated additional deep apical biopsy enhances cancer detection in palpably benign prostate gland.
    Int J Urol. 2006;13:1290-5.
    PubMed     Related articles    Abstract available


    September 2006
  76. AOKI H , Ishidoya S, Ito A, Endoh M, et al
    Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate.
    Int J Urol. 2006;13:1254-8.
    PubMed     Related articles    Abstract available


  77. SAITO S , Namiki S, Numahata K, Satoh M, et al
    Relevance of postcatheter removal incontinence to postoperative urinary function after radical prostatectomy.
    Int J Urol. 2006;13:1191-6.
    PubMed     Related articles    Abstract available


  78. SALONIA A , Suardi N, Crescenti A, Colombo R, et al
    General versus spinal anesthesia with different forms of sedation in patients undergoing radical retropubic prostatectomy: results of a prospective, randomized study.
    Int J Urol. 2006;13:1185-90.
    PubMed     Related articles    Abstract available


    July 2006
  79. KANG SH , Bae JH, Park HS, Yoon DK, et al
    Prostate-specific antigen adjusted for the transition zone volume as a second screening test: a prospective study of 248 cases.
    Int J Urol. 2006;13:910-4.
    PubMed     Related articles    Abstract available


    June 2006
  80. HAMANO S , Nakatsu H, Suzuki N, Murakami S, et al
    Usefulness of tonsil forceps in radical retropubic prostatectomy.
    Int J Urol. 2006;13:854-6.
    PubMed     Related articles    Abstract available


  81. ADAM C , Graser A, Koch W, Trottmann M, et al
    Symphysitis following transrectal biopsy of the prostate.
    Int J Urol. 2006;13:832-3.
    PubMed     Related articles    Abstract available


  82. RANNIKKO A , Krogerus L, Nyberg M, Salmela K, et al
    Rapid progression of small cell carcinoma in a renal transplant recipient.
    Int J Urol. 2006;13:817-9.
    PubMed     Related articles    Abstract available


    April 2006
  83. MANIKANDAN R , Nathaniel C, Reeve N, Brough RJ, et al
    Bilateral testicular metastases from prostatic carcinoma.
    Int J Urol. 2006;13:476-7.
    PubMed     Related articles    Abstract available


  84. AL-MUFARREJ F , Kamel MH, Mohan P, Hickey D, et al
    Tricorporal priapism postradical cystoprostatectomy: first sign of recurrent urogenital malignancy.
    Int J Urol. 2006;13:460-2.
    PubMed     Related articles    Abstract available


  85. NOGUCHI M , Shimada A, Nakashima O, Kojiro M, et al
    Urodynamic evaluation of a suspension technique for rapid recovery of continence after radical retropubic prostatectomy.
    Int J Urol. 2006;13:373-8.
    PubMed     Related articles    Abstract available


  86. SAKAI I , Harada K, Kurahashi T, Yamanaka K, et al
    Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
    Int J Urol. 2006;13:368-72.
    PubMed     Related articles    Abstract available


  87. HACHIYA T , Ichinose T, Hirakata H, Kawata N, et al
    Prostate-specific antigen failure within 2 years of radical prostatectomy predicts overall survival.
    Int J Urol. 2006;13:362-7.
    PubMed     Related articles    Abstract available


    March 2006
  88. LEE HM , Song SY, Park JO, Kim BH, et al
    Primary immature teratoma of the prostate with angiosarcoma component: its unusual response to chemotherapy.
    Int J Urol. 2006;13:305-7.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: